Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH (DIM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
91.8(c) 93.4(c) 93.25(c) 94.55(c) 94.9(c) Last
29 339 38 074 44 519 72 377 36 687 Volume
+2.00% +1.74% -0.16% +1.39% +0.37% Change
More quotes
Financials (EUR)
Sales 2018 1 164 M
EBIT 2018 260 M
Net income 2018 186 M
Debt 2018 131 M
Yield 2018 0,55%
Sales 2019 1 298 M
EBIT 2019 299 M
Net income 2019 215 M
Debt 2019 61,4 M
Yield 2019 0,63%
P/E ratio 2018 46,76
P/E ratio 2019 39,44
EV / Sales2018 7,63x
EV / Sales2019 6,79x
Capitalization 8 748 M
More Financials
Company
Sartorius Stedim Biotech SA manufactures and supplies biopharmaceutical products and medical equipment.It offers laboratory equipment for cell cultivation, weighing, water purification, liquid handling and filtration.The company services include customer support, laboratory training courses, and... 
More about the company
Surperformance© ratings of Sartorius Stedim Biotech
Trading Rating : Investor Rating :
More Ratings
Latest news on SARTORIUS STEDIM BIOTECH
07/11SARTORIUS STEDIM BIOTECH : and Penn State partner to advance teaching, research ..
AQ
07/02SARTORIUS STEDIM BIOTECH SA : Half-year report of the liquidity contract with th..
EQ
06/14SARTORIUS STEDIM BIOTECH : And Siemens Sign Long-Term Cooperation Agreement In T..
AQ
06/13SARTORIUS STEDIM BIOTECH : Siemens and Sartorius sign automation agreement
AQ
06/12SARTORIUS STEDIM BIOTECH : and Siemens sign long-term cooperation agreement in t..
PU
05/14Pharmaceutical Membrane Filters Market by Current Scenario, Key Vendors, Grow..
AQ
04/25SARTORIUS STEDIM BIOTECH : and Penn State partner to advance biotech teaching an..
AQ
04/24SARTORIUS STEDIM BIOTECH : launches mini bioreactor vessel for ambr 250 high thr..
AQ
04/20SARTORIUS STEDIM BIOTECH SA : Change of the liquidity contract
EQ
04/18SARTORIUS STEDIM BIOTECH : and Penn State partner to advance teaching and resear..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/11MEDTRONIC : Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure
DJ
07/09BECTON DICKINSON AND : Completes Acquisition of TVA Medical
DJ
06/29ESSILOR INTERNATIONAL : Luxottica, Essilor extend deadline for merger pending Ch..
RE
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
4-Traders Strategies on SARTORIUS STEDIM BIOTECH 
SARTORIUS STEDIM BIO - 2017
A reversal of the trend is being expected
SELL
SARTORIUS STEDIM BIO - 2017
Expect the comeback of a strong trend
BUY
More Strategies
Latest Tweets
07/03Sartorius : Sustainable business – Sartorius signs the United Nations Globa.. 
07/02Sartorius Stedim Biotech SA: HALF-YEAR REPORT OF THE LIQUIDITY CONTRACT WITH .. 
07/02Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND.. 
06/05Sartorius given €94.00 PT by HSBC. sell rating.  
06/04Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND.. 
More tweets
Qtime:49
News from SeekingAlpha
04/24Sartorius Stedim Biotech reports Q1 results 
02/22Sartorius Stedim Biotech (SDMHF) Investor Presentation - Slideshow 
01/31Sartorius Stedim Biotech 2017 Q4 - Results - Earnings Call Slides 
01/31Sartorius Stedim Biotech reports FY results 
2017Sartorius AG 2017 Q3 - Results - Earnings Call Slides 
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | 4-Traders
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 79,2 €
Spread / Average Target -17%
EPS Revisions
Managers
NameTitle
Joachim Kreuzburg Chairman, CEO, CFO & Head-Human Resources
Volker Niebel Executive VP-Operations & Information Technology
Oscar-Werner Reif Executive VP-Research & Development
Liliane de Lassus Independent Non-Executive Director
Bernard Lemaître Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS STEDIM BIOTECH57.41%10 221
MEDTRONIC PLC8.82%119 437
BAXTER INTERNATIONAL15.69%40 217
ALIGN TECHNOLOGY63.58%29 130
ZIMMER BIOMET HOLDINGS-4.79%23 354
HOYA CORPORATION10.59%21 544